Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients

Acta Neuropathologica

Volumn 128, Issue 5, 2014, Pages 651-663

  Grozdanov, Veselin ^a   Bliederhaeuser, Corinna ^a   Ruf, Wolfgang P ^a   Roth, Valerie ^a   Fundel Clemens, Kathrin ^c   Zondler, Lisa ^a   Brenner, David ^b   Martin Villalba, Ana ^b   Hengerer, Bastian ^c   Kassubek, Jan ^a   Ludolph, Albert C ^a   Weishaupt, Jochen H ^a   Danzer, Karin M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Blood monocytes; CCL2; FAS FASLG; Inflammation; Parkinson s disease

Indexed keywords

CD14 ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PROTEIN FOS; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR FOSB; CULTURE MEDIUM; CYTOKINE; LEUKOCYTE ANTIGEN;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SUBPOPULATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE RELEASE; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; MONOCYTE; MONOCYTE CULTURE; NATURAL KILLER CELL; NEXT GENERATION SEQUENCING; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; COHORT ANALYSIS; COMPLICATION; CULTURE MEDIUM; DRUG EFFECTS; FEMALE; MALE; METABOLISM; PATHOLOGY; PSYCHOLOGICAL RATING SCALE;

ANTIGENS, CD; CELLS, CULTURED; CHEMOKINE CCL2; COHORT STUDIES; CULTURE MEDIA; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; PARKINSON DISEASE; PHAGOCYTOSIS; PSYCHIATRIC STATUS RATING SCALES; RNA, MESSENGER;

EID: 84921938850     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1345-4     Document Type: Article

References (44)

1. Ahmed I, Tamouza R, Delord M, Krishnamoorthy R, Tzourio C, Mulot C, Nacfer M, Lambert JC, Beaune P, Laurent-Puig P, Loriot MA, Charron D, Elbaz A (2012) Association between Parkinson’s disease and the HLA-DRB1 locus. Mov Disord 27(9):1104–1110. doi:10.1002/mds.25035
2. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142–1149. doi:10.1038/nn.2887
3. Appel SH, Beers DR, Henkel JS (2010) T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31:7–17. doi:10.1016/j.it.2009.09.003
4. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27:669–692. doi:10.1146/annurev.immunol.021908.132557
5. Beier CP, Schulz JB (2009) CD95/Fas in the brain–not just a killer. Cell Stem Cell 5:128–130. doi:10.1016/j.stem.2009.07.008
6. Boddeke EW, Meigel I, Frentzel S et al (1999) Cultured rat microglia express functional beta-chemokine receptors. J Neuroimmunol 98:176–184
7. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA (2006) Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 67:494–496. doi:10.1212/01.wnl.0000227906.99570.cc
8. Brochard V, Combadiere B, Prigent A et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182–192. doi:10.1172/JCI36470
9. Butovsky O, Siddiqui S, Gabriely G et al (2012) Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122:3063–3087. doi:10.1172/JCI62636
10. Butovsky O, Jedrychowski MP, Moore CS et al (2014) Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17:131–143. doi:10.1038/nn.3599
11. Chen H, O’Reilly EJ, Schwarzschild MA, Ascherio A (2008) Peripheral inflammatory biomarkers and risk of Parkinson’s disease. Am J Epidemiol 167:90–95. doi:10.1093/aje/kwm260
12. Choi C, Benveniste EN (2004) Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 44:65–81
13. Cros J, Cagnard N, Woollard K et al (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33:375–386. doi:10.1016/j.immuni.2010.08.012
14. Cunningham C, Campion S, Lunnon K et al (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65:304–312. doi:10.1016/j.biopsych.2008.07.024
15. Czeslick EG, Simm A, Grond S, Silber RE, Sablotzki A (2003) Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Invest 33:1013–1017
16. D’Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29:2089–2102. doi:10.1523/JNEUROSCI.3567-08.2009
17. Deleidi M, Gasser T (2013) The role of inflammation in sporadic and familial Parkinson’s disease. Cell Mol Life Sci 70:4259–4273. doi:10.1007/s00018-013-1352-y
18. Depboylu C, Stricker S, Ghobril JP, Oertel WH, Priller J, Hoglinger GU (2012) Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp Neurol 238:183–191. doi:10.1016/j.expneurol.2012.08.020
19. Djukic M, Mildner A, Schmidt H et al (2006) Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129:2394–2403. doi:10.1093/brain/awl206
20. Fu K, Ren H, Wang Y, Fei E, Wang H, Wang G (2012) DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD. Oncogene 31:1311–1322. doi:10.1038/onc.2011.315
21. Funk N, Wieghofer P, Grimm S et al (2013) Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson’s disease. Mov Disord 28:392–395. doi:10.1002/mds.25300
22. Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS (2011) Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease. Environ Health Perspect 119:807–814. doi:10.1289/ehp.1003013
23. Gardai SJ, Mao W, Schule B et al (2013) Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson’s disease. PLoS ONE 8:e71634. doi:10.1371/journal.pone.0071634
24. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82
25. Harms AS, Cao S, Rowse AL et al (2013) MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33:9592–9600. doi:10.1523/JNEUROSCI.5610-12.2013
26. Harris MA, Tsui JK, Marion SA, Shen H, Teschke K (2012) Association of Parkinson’s disease with infections and occupational exposure to possible vectors. Mov Disord 27:1111–1117. doi:10.1002/mds.25077
27. Hasegawa Y, Inagaki T, Sawada M, Suzumura A (2000) Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson’s disease. Acta Neurol Scand 101:159–164
28. Hayley S, Crocker SJ, Smith PD et al (2004) Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. J Neurosci 24:2045–2053. doi:10.1523/JNEUROSCI.4564-03.2004
29. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
30. Landau AM, Luk KC, Jones ML et al (2005) Defective Fas expression exacerbates neurotoxicity in a model of Parkinson’s disease. J Exp Med 202:575–581. doi:10.1084/jem.20050163
31. Letellier E, Kumar S, Sancho-Martinez I et al (2010) CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 32:240–252. doi:10.1016/j.immuni.2010.01.011
32. Mildner A, Mack M, Schmidt H et al (2009) CCR2+ Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132:2487–2500. doi:10.1093/brain/awp144
33. Nguyen MD, D’Aigle T, Gowing G, Julien JP, Rivest S (2004) Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci 24:1340–1349. doi:10.1523/JNEUROSCI.4786-03.2004
34. Park DR, Thomsen AR, Frevert CW et al (2003) Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 170:6209–6216
35. Reale M, Iarlori C, Thomas A et al (2009) Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun 23:55–63. doi:10.1016/j.bbi.2008.07.003
36. Saha P, Geissmann F (2011) Toward a functional characterization of blood monocytes. Immunol Cell Biol 89:2–4. doi:10.1038/icb.2010.130
37. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311–317. doi:10.1038/ni1309
38. Solomon JN, Lewis CA, Ajami B, Corbel SY, Rossi FM, Krieger C (2006) Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia 53:744–753. doi:10.1002/glia.20331
39. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18:207–208
40. Stypula G, Kunert-Radek J, Stepien H, Zylinska K, Pawlikowski M (1996) Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson’s disease. NeuroImmunoModulation 3:131–134
41. Tuettenberg J, Seiz M, Debatin KM et al (2012) Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients. Int Immunopharmacol 13:93–100. doi:10.1016/j.intimp.2012.03.004
42. Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H (2013) Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet. 93(5):984–993. doi:10.1016/j.ajhg.2013.10.009
43. Yona S, Jung S (2010) Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 17:53–59. doi:10.1097/MOH.0b013e3283324f80
44. Ziegler-Heitbrock L, Ancuta P, Crowe S et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74–e80. doi:10.1182/blood-2010-02-258558